Categories

Meta

Recent Posts

Archive for April, 2010

Principals of StemTroniX, Power3 Medical Products row unmistakable practice

Posted in Medical Patent on April 30th, 2010

StemTroniX, Inc., a Texas corporation, and Power3 Medical Products, Inc. (OTCBB: PWRM – Word announced today that a juncture probationary explicit utilization entitled, "Stem Stall Protein Biomarkers and Their Permission in Monitoring Originate Cells and Their Products because Stem-post Apartment Therapy" has been filed around the principals of StemTroniX and Power3 with the Collaborative States Prominent and Trademark Obligation. The Read the rest of this entry »

Ardea Biosciences reports belittle grid collapse of $10.1M for the treatment of first-quarter 2010

Posted in Drug Trial on April 30th, 2010

Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology presence focused on the maturation of small-molecule therapeutics benefit of the treatment of gout, cancer and considerate immunodeficiency virus (HIV), today reported up to date accomplishments and pecuniary results for the sake the from the start residence ended Hike 31, 2010.

"We are glad to obtain consummate a billion of least momentous objectives since our model every Read the rest of this entry »

AHF’s Charming Johnson Testing America Drive arrives in Minneapolis to proposal sovereign HIV testing

Posted in Disease, Infection on April 30th, 2010

AIDS Healthcare Raison detre:

“It is essential that people be familiar with their HIV eminence and congregate how to traverse b recover fetching infected with HIV; or if they are infected, be aware their importance, and quest after medical treatment, if needed”

AHF’s Obeahism Johnson ‘Testing America’ Round, a six month, 48 situation patriotic grumpy woods HIV testing junket, arrives in Minneapolis today and last wishes Read the rest of this entry »

USPTO grants evident conducive to Quick-Med’s proprietary NIMBUS polymeric antimicrobial technology

Posted in Medical Patent on April 30th, 2010

Quick-Med Technologies, Inc. (OTCBB:QMDT), a chairperson in developing innovative antimicrobial technologies for the benefit of the healthcare and consumer markets, today announced that it has been granted U.S. Grant No. 7,709,694 from the Synergistic States Copyright and Trademark Commission (USPTO). The palpable to go to company’s proprietary NIMBUS® polymeric antimicrobial technology is seemly to a genre of establish materials including woven Read the rest of this entry »

CT expertise is more exact than X-rays in detecting thoracic, lumbar thorn fractures: Over

Posted in Child Health on April 30th, 2010

When trauma patients make a computed tomography (CT) read over of the casket, abdomen, and pelvis, a aptitude called CT prickle reformatting eliminates the dire fit X-rays of the thoracic and/or lumbar prong to catch spinal fractures. This art can slash bring in and whole assiduous diffusion outlook, according to a analyse to be presented at the ARRS 2010 Annual Assignation in San Diego, CA.

CT quill reformatting is performed close a Read the rest of this entry »

Celldex reports grid impoverishment of $6.6 million seeking first-quarter 2010

Posted in Drug Trial on April 30th, 2010

Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported economic results allowing for regarding the from the word go locale ended Slog 31, 2010. Celldex reported a reticle impairment of $6.6 million, or $0.21 per part, after the initially shelter of 2010 compared to a after deductions harm of $7.7 million, or $0.49 per interest, suited for the outset phase of the moon of 2009. At Step 31, 2010, Celldex reported currency, change equivalents and Read the rest of this entry »

Tomophase receives seventh U.S. Franchise on OCTIS component

Posted in Medical Patent on April 29th, 2010

Tomophase Corporation, a cardinal developer of non-invasive optical coherence tomography (OCT) conglomeration imaging devices, announced today that it has received notification of the issuance of its seventh charter: Delivering Delicate via Optical Waveguide and Multi-view Optical Investigation Climax, U. S. Conspicuous # 7,706,646.

“We are chuffed to notified of this manifest which we swear by ordain gain the adjustability of OCTIS Read the rest of this entry »

DUSA Pharmaceuticals receives mind of credit seeing that franchise covering morose scatterbrained technology

Posted in Medical Patent on April 29th, 2010

DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology ensemble that is developing and marketing Levulan® Photodynamic Psychotherapy (PDT), today announced that the Partnership States Conspicuous and Trademark Occupation has issued a intimation of recompense conducive to a crucial control common to its proprietary PDT bearing in mind explain horses mouth, the BLU-U®, Risqu Window Photodynamic Group therapy Illuminator.  The creative Read the rest of this entry »

Researchers winnow effects of sluggishness on neurosurgery home-owner conduct

Posted in Medical Research on April 29th, 2010

There are more than 6,000 U.S. hospitals, with around 3,500 actively practicing board-certified neurosurgeons serving a residents of during the course of 303 million people. Respecting 150 neurosurgery residents graduate every year from the 99 accredited U.S. neurosurgery training programs. Since July 2003, residents in most programs give birth to been reduced to an 80-hour foil week, although in some programs they are allowed to spur up to 88 Read the rest of this entry »

Merrion Pharmaceuticals increases flagrant bulwark in requital for Orazol

Posted in Medical Patent on April 29th, 2010

Merrion Pharmaceuticals plc (IEX:MERR), a pharmaceutical incident new zealand, today announces that it has been granted a service U.S. Charter, increasing the aegis owing their beguile output, Orazol™.

Merged States Letters patent No. 7,704,977, "Solid Spoken Dosage Turn out Containing an Enhancer" covers Orazol™ tablets, an vocal frame of zoledronic acid, a bisphosphonate. Orazol is in increment to nurse bone metastases Read the rest of this entry »